SELECT MEDICAL HOLDINGS CORP

Listed Company

SEMCIK 0001320414NYSELarge AcceleratedServices-HospitalsFY ends Dec 31

Period

FY 2025

Revenue

—

Net Income

—

Total Assets

$5.85B

Equity

$1.71B

Shares Out

124.02M

Op. Cash Flow

$346.47M

Business

SELECT MEDICAL HOLDINGS CORP operates long‑term post‑acute healthcare facilities specializing in care for patients with complex medical and rehabilitation needs. It provides critical illness recovery hospitals certified as LTCHs, inpatient rehabilitation hospitals (IRFs), and outpatient rehabilitation clinics offering physical, occupational, and speech therapy and specialized programs such as ventilator weaning, wound care, pelvic health, and cancer rehabilitation. The company manages three business segments: critical illness recovery hospitals, rehabilitation hospitals, and outpatient rehabilitation, along with corporate and employee‑leasing activities. It operates nationwide across 40 states and the District of Columbia through HIH arrangements, free‑standing hospitals, clinics, and joint ventures with healthcare systems.

Summary from filing dated 2025-02-20

Financials

Consolidated Statement of Income

Year Ended · In millions, except per-share amounts

Concept	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31
Net income attributable to non-controlling interests	63	73	48	31	48
Cash dividends declared for common stockholders	−31	−65	−64	−65	−51
Issuance of restricted stock	0	0	0	0	0
Forfeitures of unvested restricted stock	18,000	71,000	12,000	64,000	—
Vesting of restricted stock	17	101	44	36	29
Repurchase of common shares	−101	−38	−13	−196	−79
Issuance of non-controlling interests	16	27	23	10	21
Non-controlling interests acquired in business combination	—	13	9	12	11
Distributions to and purchases of non-controlling interests	−73	−50	−55	−38	−72
Redemption value adjustment on non-controlling interests	−4,000	−2	2	3	−250
Concentra Separation and Distribution	—	209	—	—	—
Other comprehensive loss	−6	−43	−46	—	—
Other	—	129,000	−34,000	37,000	4,000

Consolidated Balance Sheet

As of · In millions, except per-share amounts

Concept	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31
Cash and cash equivalents	27	60	53	98	74
Accounts receivable	864	821	724	941	889
Prepaid income taxes	20	27	15	32	56
Other current assets	115	112	116	125	120
Total Current Assets	1,025	1,020	1,258	1,271	1,139
Operating lease right-of-use assets	958	908	791	1,170	1,079
Property and equipment, net	992	872	845	—	—
Goodwill	2,361	2,332	2,283	2,258	3,449
Identifiable intangible assets, net	101	103	105	352	375
Other assets	414	373	368	342	339
Total Assets	5,852	5,608	7,690	7,665	7,360
Overdrafts	17	26	30	32	42
Current operating lease liabilities	188	180	172	237	229
Current portion of long-term debt and notes payable	24	20	69	44	18
Accounts payable	157	142	154	187	234
Accrued and other liabilities	598	610	552	—	—
Total Current Liabilities	984	978	1,248	1,155	1,273
Non-current operating lease liabilities	835	787	669	1,008	917
Long-term debt, net of current portion	1,804	1,692	3,584	3,835	3,556
Non-current deferred tax liability	112	81	120	170	143
Other non-current liabilities	80	73	83	106	106
Total Liabilities	3,816	3,611	6,116	6,275	5,995
Commitments and contingencies (Note 19)	—	—	—	—	—
Redeemable non-controlling interests	19	10	26	34	39
Common stock, $0.001 par value, 700,000,000 shares authorized, 128,962,850 and 124,017,191 shares issued and outstanding at 2024 and 2025, respectively	124,000	129,000	128,000	127,000	134,000
Capital in excess of par	875	911	493	452	504
Retained earnings	837	770	752	581	593
Accumulated other comprehensive loss	−6	0	43	89	12
Total Stockholders Equity	1,706	1,681	1,288	1,122	1,110
Non-controlling interests	311	306	259	235	216
Total Equity	2,017	1,987	1,548	1,357	1,326
Total Liabilities and Equity	5,852	5,608	7,690	7,665	7,360

Consolidated Statement of Cash Flows

Year Ended · In millions, except per-share amounts

Concept	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31
Distributions from unconsolidated subsidiaries	53	39	23	22	37
Depreciation and amortization	140	204	209	206	—
Provision for expected credit losses	2	4	1	174,000	236,000
Equity in earnings of unconsolidated subsidiaries	−55	−60	−41	−26	—
Loss on extinguishment of debt	0	19	175,000	0	0
(Gain) loss on sale or disposal of assets	8,000	−1	−57,000	−3	—
Stock compensation expense	17	101	44	38	31
Amortization of debt discount, premium and issuance costs	3	3	3	2	2
Deferred income taxes	31	−32	−16	8	—
Accounts receivable	−45	−96	1	−52	23
Other current assets	413,000	18	−29	−5	−2
Other assets	−9	13	10	16	−7
Accounts payable	−854,000	−17	−6	−48	53
Accrued expenses	−5	26	84	13	−73
Net cash provided by operating activities	346	518	582	285	401
Business combinations, net of cash acquired	−9	−13	−30	−27	−82
Purchases of property, equipment, and other assets	−229	−222	−229	−190	−181
Investment in businesses	−1	0	−10	−17	−21
Proceeds from sales and exchanges of assets and sale of business	23	4	163,000	—	—
Net cash used in investing activities	−216	−231	−268	−226	−257
Borrowings on revolving facilities	1,290	1,240	905	1,120	160
Payments on revolving facilities	−1,295	−1,415	−1,070	−835	0
Proceeds from term loans, net of issuance costs	0	1,880	2,092	0	0
Payments on term loans	−11	−2,092	−2,114	0	0
Payment on senior notes, including call premium	0	−1,238	0	0	—
Proceeds from senior notes, net of issuance costs	0	1,177	0	0	—
Borrowings of other debt	101	25	31	26	33
Principal payments on other debt	−34	−65	−47	−36	−40
Dividends paid to common stockholders	−31	−65	−64	−65	−51
Repurchase of common stock	−100	−38	−13	−196	−79
Decrease in overdrafts	−9	−4	−2	−10	42
Proceeds from issuance of non-controlling interests	16	16	23	10	21
Distributions to and purchases of non-controlling interests	−90	−60	−64	−43	−73
Purchase of membership interests of Concentra Group Holdings Parent	0	0	−6	−6	−661
Proceeds from Concentra initial public offering	0	511	0	0	—
Cash transferred to Concentra at separation	0	−182	0	0	—
Net cash used in financing activities	−163	−311	−327	−35	−647
Net decrease in cash and cash equivalents	−33	−24	−14	24	−503
Cash paid for interest, excluding amounts received of $82,818 and $68,069 under the interest rate cap contract for the years ended December 31, 2023 and 2024, respectively.	121	256	272	183	132
Cash paid for taxes	26	133	89	32	181
Liabilities for purchases of property and equipment	36	22	18	52	23

Filings

Filing historySign up free to browse every 10-K, 10-Q, 8-K, and proxy this filer has submitted to the SEC.Sign up free · Upgrade to Pro

Material Events

Material EventsTrack every 8-K filing and material event — AI-summarized, timelined, and alertable.Sign up free · Upgrade to Pro

Insiders

Insider ActivitySee executive buy/sell windows and insider trade activity over rolling 30/90/365-day windows.Sign up free · Upgrade to Pro

Institutional Holders

Institutional HoldersSee which funds hold this stock and track position changes quarter over quarter.Sign up free · Upgrade to Pro